BLOODY USEFUL ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.6% 11.9% 12.7% 13.2% 14.7%  
Credit score (0-100)  22 20 17 17 13  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  361 444 429 279 220  
EBITDA  -134 -40.2 -77.7 -40.1 18.0  
EBIT  -140 -42.7 -77.7 -40.1 18.0  
Pre-tax profit (PTP)  -141.8 -44.6 -79.6 -53.6 2.2  
Net earnings  -176.5 -106.3 -79.6 -53.6 2.2  
Pre-tax profit without non-rec. items  -142 -44.6 -79.6 -53.6 2.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  2.5 0.0 0.0 0.0 0.0  
Shareholders equity total  -161 -267 -347 -400 -398  
Interest-bearing liabilities  220 234 291 387 404  
Balance sheet total (assets)  152 184 106 114 121  

Net Debt  203 118 274 339 320  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  361 444 429 279 220  
Gross profit growth  -17.3% 22.9% -3.4% -35.1% -20.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  152 184 106 114 121  
Balance sheet change%  -49.9% 21.2% -42.3% 6.9% 6.2%  
Added value  -133.7 -40.2 -77.7 -40.1 18.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -12 -5 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -38.7% -9.6% -18.1% -14.4% 8.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -45.4% -11.1% -17.0% -8.3% 3.5%  
ROI %  -65.0% -18.7% -29.2% -11.8% 4.6%  
ROE %  -210.8% -63.3% -54.9% -48.8% 1.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -51.4% -59.2% -76.5% -77.9% -76.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -152.1% -293.0% -352.1% -844.4% 1,778.8%  
Gearing %  -136.5% -87.7% -84.1% -96.8% -101.4%  
Net interest  0 0 0 0 0  
Financing costs %  1.0% 1.0% 1.1% 4.0% 4.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.5 0.4 0.2 0.2 0.2  
Current Ratio  0.5 0.4 0.2 0.2 0.2  
Cash and cash equivalent  16.1 116.6 17.8 48.7 83.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -169.1 -267.1 -346.8 -400.4 -401.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -134 -40 -78 -40 18  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -134 -40 -78 -40 18  
EBIT / employee  -140 -43 -78 -40 18  
Net earnings / employee  -176 -106 -80 -54 2